この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1998/10/191 分で読めます
Determination That Sutilains Ointment USP Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing its determination that sutilains ointment USP (Travase Ointment) was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDA's) for sutilains ointment USP.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →